EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Candidemia in ICU Patients: What Are the Real Game-Changers for Survival?

Bianca Leal de Almeida, Caroline Agnelli, Thaís Guimarães iD, Teresa Sukiennik, Paulo Roberto Passos Lima, Mauro José Costa Salles iD, Giovanni Luís Breda, Flavio Queiroz-Telles iD, Ana Verena Almeida Mendes, Luís Fernando Aranha Camargo, Hugo Manuel Paz Morales, Viviane Maria de Carvalho Hessel Dias und 8 weitere

Journal of Fungi · 17.02.2025 · 11 (2) · 152

DOI: 10.3390/jof11020152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Fungi, online erschienen am 17.02.2025. Verfasst von Bianca Leal de Almeida und 19 weiteren Autor:innen. Beteiligte Einrichtung: Instituto do Câncer do Estado de São Paulo, School of Medicine, Hospital Infection Control and Infectious Diseases Service, University of São Paulo, …. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FUNDAÇÃO DE AMPARO A PESQUISA DO ESTADO DE SÃO PAULO, BRAZIL, CAPES Foundation, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Candidemia infection remains a critical challenge in intensive care units (ICUs), with high morbidity and mortality rates despite advances in therapeutic practices. This multicenter prospective surveillance study assessed the epidemiology, clinical management, and mortality predictors of candidemia in critically ill patients across two periods (2010–2012 and 2017–2018) in 11 tertiary hospitals in Brazil. Among 314 ICU patients with candidemia, the overall mortality rate was 60.2%, with no significant reduction over time (58.8% vs. 62.6%, p = 0.721). Candida albicans was the predominant pathogen (43.6%), followed by C. tropicalis (20%) and C. glabrata (13.7%). The use of echinocandins increased significantly in the second period (21.1% to 41.7%, p < 0.001); however, 70% of patients still did not receive these agents as first-line therapy. Catheter removal due to candidemia was performed in only 52.1% of cases but was associated with improved 30-day survival (p < 0.001). Multivariate analysis identified cancer, inadequate treatment, and vasoactive drug use as independent predictors of mortality. Our findings underscore persistent gaps in adherence to guidelines, particularly regarding timely echinocandin initiation and catheter removal. Strengthening therapeutic strategies focused on these key interventions is essential to improving outcomes for ICU patients with candidemia.

Schlagwörter

Stichwörter der Autor:innen

cancercandidemiacatheter removalechinocandinsintensive care unit

Autor:innen und Institutionen

  • Instituto do Câncer do Estado de São Paulo, School of Medicine, Hospital Infection Control and Infectious Diseases Service, University of São Paulo, São Paulo 01246-000, Brazil.
  • Division of Infectious Diseases, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo 04024-002, Brazil.
  • Hospital das Clínicas da Faculdade de Medicina USP (FMUSP), São Paulo 05403-010, Brazil.
  • Hospital do Servidor Público Estadual de São Paulo, São Paulo 04039-000, Brazil.
  • Santa Casa de Misericórdia de Porto Alegre, Porto Alegre 90050-170, Brazil.
  • Santa Casa de Misericórdia de São Paulo, São Paulo 01221-010, Brazil.

ORCID-Profile: Thaís Guimarães, Mauro José Costa Salles, Flavio Queiroz-Telles, Afonso Rafael da Silva Junior, João Nóbrega de Almeida Junior, Camila de Melo Picone, Evangelina da Motta Pacheco Alves de Araújo, Edson Abdala, Arnaldo Lopes Colombo, Marcello Mihailenko Chaves Magri

Förderung

  • FUNDAÇÃO DE AMPARO A PESQUISA DO ESTADO DE SÃO PAULO, BRAZIL
  • CAPES Foundation
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Antimicrobial Resistance Institute of São Paulo (ARIES) and CAPES Foundation

Zitieren

APA

de Almeida, B. L., Agnelli, C., Guimarães, T., Sukiennik, T., Lima, P. R. P., Salles, M. J. C., Breda, G. L., Queiroz-Telles, F., Mendes, A. V. A., Camargo, L. F. A., Morales, H. M. P., Dias, V. M. C. H., da Silva Junior, A. R., de Almeida Junior, J. N., Picone, C. M., de Araújo, E. D. M. P. A., Abdala, E., Rossi, F., Colombo, A. L., & Magri, M. M. C. (2025). Candidemia in ICU Patients: What Are the Real Game-Changers for Survival?. Journal of Fungi, 11(2), 152. https://doi.org/10.3390/jof11020152

Vancouver

de Almeida BL, Agnelli C, Guimarães T, Sukiennik T, Lima PRP, Salles MJC, et al. Candidemia in ICU Patients: What Are the Real Game-Changers for Survival?. Journal of Fungi. 2025;11(2):152. doi:10.3390/jof11020152

BibTeX
@article{deAlmeida2025,
  author = {de Almeida, Bianca Leal and Agnelli, Caroline and Guimarães, Thaís and Sukiennik, Teresa and Lima, Paulo Roberto Passos and Salles, Mauro José Costa and Breda, Giovanni Luís and Queiroz-Telles, Flavio and Mendes, Ana Verena Almeida and Camargo, Luís Fernando Aranha and Morales, Hugo Manuel Paz and Dias, Viviane Maria de Carvalho Hessel and da Silva Junior, Afonso Rafael and de Almeida Junior, João Nóbrega and Picone, Camila de Melo and de Araújo, Evangelina da Motta Pacheco Alves and Abdala, Edson and Rossi, Flávia and Colombo, Arnaldo Lopes and Magri, Marcello Mihailenko Chaves},
  title = {Candidemia in ICU Patients: What Are the Real Game-Changers for Survival?},
  journal = {Journal of Fungi},
  year = {2025},
  volume = {11},
  number = {2},
  pages = {152},
  doi = {10.3390/jof11020152}
}
Kostenlos starten →